Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

Phase 4 Completed 33 enrolled NHS Greater Glasgow and Clyde Queen's University, Belfast · collab

RandomizedCrossoverQuadruple-blindOther

Summary

The aim of the project is to study the persistence of inflammation after addition of an interleukin-5 (IL-5) blocker in severe eosinophilic asthma as a study of untreated pathways in these patients.

Timeline

Start: 2018-10-19
Primary completion: 2020-01-07
Completion: 2020-01-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Prednisolone	Other / unclassified	0.5 mg/kg	Oral

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

Summary

Timeline

Drugs

Indications